Research Paper Volume 16, Issue 6 pp 5027—5037
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress
Figure 2. Treatment with PHN-20 alleviated hypoxia-induced pulmonary vascular remodeling in rats. The percentage of pulmonary arterial wall thickness (W%) was calculated. (*, P<0.05 vs. control group; #, P<0.05 vs. hypoxia group).